Arrhythmogenic Toxicity in Radiotherapy: Cardiac Conduction System as an Emerging Organ at Risk
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F25%3A10504277" target="_blank" >RIV/00064203:_____/25:10504277 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11130/25:10504277
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=9J80EITHxq" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=9J80EITHxq</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s44411-025-00356-6" target="_blank" >10.1007/s44411-025-00356-6</a>
Alternative languages
Result language
angličtina
Original language name
Arrhythmogenic Toxicity in Radiotherapy: Cardiac Conduction System as an Emerging Organ at Risk
Original language description
BackgroundCardiovascular disease is the most common non-oncologic cause of death in patients treated with radiotherapy in thoracic region. Radiation-induced heart disease (RIHD) includes a range of structural and functional complications, among which arrhythmogenic toxicity-conduction disorders and arrhythmias-has gained increasing attention. The cardiac conduction system is not routinely delineated as an organ at risk (OAR), nor are the surrounding structures such as the pulmonary veins, which represent a key pathophysiological site in the development of supraventricular arrhythmias. Traditional parameters like mean heart dose (MHD) may not adequately reflect regional radiosensitivity, particularly in anatomically distinct substructures located at the base of the heart, such as the sinoatrial (SA) and atrioventricular (AV) nodes.AimThis review summarizes current evidence on the effects of radiotherapy on the cardiac conduction system and highlights emerging data on its role in arrhythmogenic toxicity.ConclusionRadiation-induced arrhythmias can occur early after treatment. The heart's heterogeneous radiosensitivity challenges the use of mean heart dose (MHD) as a predictive metric. Recent studies suggest that cardiac substructures, especially the base of the heart, may be critical regions. A shift toward substructure-specific dosimetry is needed. Recently, arrhythmogenic cardiotoxicity has attracted greater interest in lung cancer, as improvements in overall survival with immunotherapy and targeted agents have increased the relevance of long-term treatment-related toxicities, including radiation-induced arrhythmias.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Bratislavské lekárske listy / Bratislava Medical Journal
ISSN
0006-9248
e-ISSN
1336-0345
Volume of the periodical
126
Issue of the periodical within the volume
12
Country of publishing house
SK - SLOVAKIA
Number of pages
13
Pages from-to
3306-3318
UT code for WoS article
001591965200001
EID of the result in the Scopus database
2-s2.0-105018778529